Institution statistics

ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI - Italy 

This institution has been merged with: MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH.

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
Networking Rank (Reputation):400-500
Partner Constancy:700-800
Project Leadership Index:800-900
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:67
Total Project Funding:300-400
Partner Constancy:58
Project Leadership Index:64
Diversity Index:40
2012
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:60
Total Project Funding:100-200
Networking Rank (Reputation):200-300
Networking Rank (Reputation):200-300
Partner Constancy:32
Project Leadership Index:60
Diversity Index:60
2011
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:200-300
Total Number of Projects:400-500
Total Project Funding:600-700
Networking Rank (Reputation):600-700
Partner Constancy:800-900
Project Leadership Index:100-200
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:400-500
Total Number of Projects:700-800
Total Project Funding:500-600
Networking Rank (Reputation):900-1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:800-900
Total Number of Projects:400-500
Total Project Funding:> 1000
Networking Rank (Reputation):700-800
Partner Constancy:800-900
Project Leadership Index:300-400
Diversity Index:300-400
2008
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Total Project Funding:300-400
Networking Rank (Reputation):400-500
Partner Constancy:500-600
Project Leadership Index:200-300
Diversity Index:600-700
2007
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:100-200
Networking Rank (Reputation):200-300
Partner Constancy:700-800
Project Leadership Index:200-300
Diversity Index:100-200
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 44
As coordinator: 5
As participant: 38
Sole participant: 1
Coordinator / Participant Ratio: 0.13*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 4.017.848 522.999 1
2018 0 5.552.269 597.999 2
2017 0 21.143.329 1.545.904 4
2016 168.277 42.884.236 1.248.342 1 2
2015 0 41.107.898 3.328.254 6
2014 0 6.799.997 297.128 1
2013 5.443.350 31.648.498 4.283.386 1 6
2012 992.666 56.348.255 3.024.824 2 9
2011 3.564.956 16.987.353 3.824.439 2 4
2010 0 16.889.532 1.958.839 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE9
ACADEMISCH ZIEKENHUIS GRONINGEN6
MEDIZINISCHE UNIVERSITAT INNSBRUCK6
UNIVERSITAET ZUERICH6
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
MEDIZINISCHE UNIVERSITAET WIEN5
MOSAIQUES DIAGNOSTICS5
UNIVERSITAETSKLINIKUM FREIBURG5
UNIVERSITAIR MEDISCH CENTRUM UTRECHT5
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM4
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O4
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
KAROLINSKA INSTITUTE4
KATHOLIEKE UNIVERSITEIT LEUVEN4
KING'S COLLEGE LONDON4
REGION HOVEDSTADEN4
SEMMELWEIS EGYETEM4
STICHTING VU4
UNIVERSITAET ULM4
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN4
UNIVERSITY OF GLASGOW4
ACADEMISCH ZIEKENHUIS LEIDEN3
ARTTIC3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA3
HEINRICHHEINEUNIVERSITAET DUESSELDORF3
INSERM TRANSFERT3
LIVERPOOL JOHN MOORES UNIVERSITY3
MEDIZINISCHE HOCHSCHULE HANNOVER3
THE PROVOST FELLOWS FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN3
THE UNIVERSITY OF MANCHESTER3
THE UNIVERSITY OF NOTTINGHAM3
UNIVERSITA DEGLI STUDI DI FIRENZE3
UNIVERSITATSKLINIKUM ERLANGEN3
UNIVERSITE PARIS DESCARTES3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF BRISTOL3
AMGEN2
AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII2
BENGURION UNIVERSITY OF THE NEGEV2
BIOTALENTUM TUDASFEJLESZTO KFT2
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
DANMARKS TEKNISKE UNIVERSITET2
DEPARTMENT OF HEALTH2
DOUGLAS CONNECT2
EDELWEISS CONNECT2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
FERRER INTERNATIONAL2
FILARETE SERVIZI2
FORSCHUNGSZENTRUM JULICH2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III2
GOETEBORGS UNIVERSITET2
HACETTEPE UNIVERSITESI2
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT2
INSTITUT CATALA DE LA SALUT2
ISTITUTO SUPERIORE DI SANITA2
KAROLINSKA INSTITUTET2
KLINIKUM DER UNIVERSITAET REGENSBURG2
KLINIKUM DER UNIVERSITAET ZU KOELN2
L'OREAL2
LEIDEN UNIVERSITY MEDICAL CENTER2
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
LUNDS UNIVERSITET2
MOLECULAR MEDICINE IRELAND LBG2
NATIONAL HELLENIC RESEARCH FOUNDATION2
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO2
POLITECNICO DI MILANO2
RANDOX CLINICS LIMITED2
SERVICIO MADRILENO DE SALUD2
STENO DIABETES CENTER2
STICHTING KATHOLIEKE UNIVERSITEIT2
TEL AVIV UNIVERSITY2
THE REGENTS OF THE UNIVERSITY OF MICHIGAN2
THE UNIVERSITY OF LIVERPOOL2
THE UNIVERSITY OF SHEFFIELD2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITAET DES SAARLANDES2
UNIVERSITAETSKLINIKUM AACHEN2
UNIVERSITAETSKLINIKUM HEIDELBERG2
UNIVERSITAT KONSTANZ2
UNIVERSITE D'AIX MARSEILLE2
UNIVERSITE DE BORDEAUX2
UNIVERSITY OF DUNDEE2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF HULL2
UNIVERSITY OF LEEDS2
UNIWERSYTET GDANSKI2
VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK NV2
WARSZAWSKI UNIWERSYTET MEDYCZNY2
ABBVIE INC1
ACCADEMIA EUROPEA PER LA RICERCA APPLICATA ED IL PERFEZIONAMENTO PROFESSIONALE BOLZANO1
ACCELOPMENT1
ACQUIFER1
ACS BIOMARKER BV1
Constancy:

Total number of partners:621

Partner loyalty:
Frequent Partner: (> 2 projects): 154
Rare Partner: 467

Frequent / Rare Partner Ratio: 0.33

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES18
RTD HORIZONTAL TOPICS10
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-01Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery TrainCKDisparticipant4.017.84811
2018-10-01Glyco-Nanoparticles for Applications in Advance Nanomedicine NanoCarbparticipant4.052.69415
2018-05-01Laser Ablation: SElectivity and monitoRing for OPTImal tuMor removAL LASER OPTIMALparticipant1.499.5754
2017-04-01European School for Interdisciplinary Tinnitus Research ESITparticipant3.823.89712
2017-01-01Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease BBDiagparticipant3.465.70815
2017-01-01European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment ESCAPE-NETparticipant9.992.88117
2017-01-01An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment in3participant3.860.84319
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-09-01Chronic kidney disease and acute kidney injury – evaluation of EU and global epidemiology CKD AKIcoordinator168.2771
2016-01-01An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century EU-ToxRiskparticipant27.798.29941
2015-11-01Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations. The TackSHS Project. TackSHSparticipant2.987.79412
2015-10-05Design of polyPEPTIdes diblock copolymers as emulsifiers to produce safe, controlled and reliable novel stimuli-responsive nanoCAPSules for skin care applications PEPTICAPSparticipant3.852.2949
2015-09-01a LOW environmental impact BRAke SYStem LOWBRASYSparticipant7.436.85011
2015-09-01Coordinated Research Infrastructures Building Enduring Life-science services CORBELparticipant14.837.80039
2015-05-01Novel Stromal Cell Therapy for Diabetic Kidney Disease NEPHSTROMparticipant5.994.37411
2015-05-01Secondary prEvention of CardiovascUlaR disease in the Elderly trial SECUREparticipant5.998.78611
2014-01-01Framework to respond to regulatory needs of future nanomaterials and markets FUTURENANONEEDSparticipant6.799.99725
2013-11-01Targets and biomarkers for antiepileptogenesis EPITARGETparticipant11.999.97518
2013-10-01Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe CREACTIVEcoordinator5.443.3509
2013-10-01MULTISCALE APPROACH TO THE IDENTIFICATION OF MOLECULAR BIOMARKERS IN ACUTE HEART FAILURE INDUCED BY SHOCK SHOCKOMICSparticipant5.174.00111
2013-08-01A Gateway to European Kidney Research Resources - KidneyConnect KIDNEYCONNECTparticipant499.97817
2013-02-01Heart OMics in AGEing HOMAGEparticipant12.000.00018
2013-01-01Predictive toxicology of engineered nanoparticles PRENANOTOXparticipant997.7343
2013-01-01"Modelling properties, interactions, toxicity and environmental behaviour of engineered nanoparticles" NANOPUZZLESparticipant976.8105
2012-12-01Translational research (training) in Polycystic Kidney Disease TRANCYSTparticipant2.763.7337
2012-11-01Stem-cell based therapy for kidney repair STELLARparticipant5.998.05013
2012-10-01European Consortium for High-Throughput Research in Rare Kidney Diseases EURENOMICSparticipant11.994.56728
2012-10-01A new paradigm in drug use and human health risk assessment: Sewage profiling at the community level SEWPROFparticipant4.178.23111
2012-09-01European Communication on Research Awareness Needs ECRANcoordinator892.6669
2012-06-01Search for novel molecules cross-talking between muscle and cancer with therapeutic potential against cachexia and cancer muscleandcancercoordinator100.0002
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01European Clinical Research Infrastructures Network - Integrating Activity ECRIN-IAparticipant7.999.93147
2012-01-01A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease NILVADparticipant5.999.97817
2012-01-01Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria PRIORITYparticipant5.980.50020
2012-01-01Building bridges between specialists on computational and empirical risk assessment of engineered nanomaterials NanoBRIDGESparticipant491.6005
2011-11-01Overcome failure to Publish nEgative fiNdings OPENparticipant499.99111
2011-05-01Dreaming of no more renal dialysis: how self-derived tissue and cells can replace renal function RESETparticipant2.493.0001
2011-02-01European multidisciplinary ALS network identification to cure motor neuron degeneration Euro-MOTORparticipant8.994.36215
2011-01-01Coordinating resources to assess and improve health status of migrants from Latin America COHEMIcoordinator1.999.96010
2011-01-01Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates TINN2participant5.000.00016
2011-01-01ToxBank – Supporting Integrated Data Analysis and Servicing of Alternative Testing Methods in Toxicology TOXBANKcoordinator1.564.99610
2010-08-01THE HYGIENE HYPOTHESIS : REVISITING THE CONCEPT BY INTEGRATING EPIDEMIOLOGY AND MECHANISTIC STUDIES HYGIENEparticipant2.099.9992
2010-07-01Fixed Dose Combination drugs for Secondary Cardiovascular Prevention FOCUSparticipant2.999.9999
2010-01-01Systems biology towards novel chronic kidney disease diagnosis and treatment SysKIDparticipant11.789.53429
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum